Related references
Note: Only part of the references are listed.YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma
Jingxia Han et al.
CANCER RESEARCH (2019)
YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway
Dongfang Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML
S. Kaushik et al.
LEUKEMIA (2018)
JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework (vol 46, pg 260, 2017)
Aziz Khan et al.
NUCLEIC ACIDS RESEARCH (2018)
The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia
J. Serio et al.
ONCOGENE (2018)
Expression of protein arginine methyltransferase-5 in oral squamous cell carcinoma and its significance in epithelial-to-mesenchymal transition
Yusuke Amano et al.
PATHOLOGY INTERNATIONAL (2018)
The Hippo pathway in normal development and cancer
Marcello Maugeri-Sacca et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature
Anello Marcello Poma et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis
Peng Yuan et al.
CANCER RESEARCH (2017)
Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth
X. Deng et al.
ONCOGENE (2017)
YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress
Si-Yao Qu et al.
CANCER MEDICINE (2017)
The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation
S. S. Tarighat et al.
LEUKEMIA (2016)
GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis
Neeraj Agarwal et al.
CANCER RESEARCH (2016)
Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia
Yanli Jin et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics
Mingjing He et al.
CELL DIVISION (2016)
Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation
Lapo Alinari et al.
BLOOD (2015)
YY1 suppresses FEN1 over-expression and drug resistance in breast cancer
Jianwei Wang et al.
BMC CANCER (2015)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
Nicole Stopa et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
YY1 regulates melanoma tumorigenesis through a miR-9 ∼ RYBP axis
Guowei Zhao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre et al.
NATURE CHEMICAL BIOLOGY (2015)
Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer
N. Wang et al.
BRITISH JOURNAL OF CANCER (2014)
Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma
Fengting Yan et al.
CANCER RESEARCH (2014)
Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition
Reem Ibrahim et al.
HUMAN PATHOLOGY (2014)
Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism
Jing-Jing Zhang et al.
MOLECULAR CANCER (2014)
Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma
Kangsheng Tu et al.
MOLECULAR CANCER (2014)
Lymph Node Ratio for Postoperative Staging of Laryngeal Squamous Cell Carcinoma with Lymph Node Metastasis
Yu-Long Wang et al.
PLOS ONE (2014)
Overexpression of PRMT5 Promotes Tumor Cell Growth and Is Associated with Poor Disease Prognosis in Epithelial Ovarian Cancer
Xiangxiang Bao et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2013)
Protein arginine methyltransferase 5 is essential for growth of lung cancer cells
Zhongping Gu et al.
BIOCHEMICAL JOURNAL (2012)
Arginine methylation controls growth regulation by E2F-1
Er-Chieh Cho et al.
EMBO JOURNAL (2012)
Transcription factors: from enhancer binding to developmental control
Francois Spitz et al.
NATURE REVIEWS GENETICS (2012)
Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation
M-H Lee et al.
ONCOGENE (2012)
Protein Arginine Methyltransferase 5 Accelerates Tumor Growth by Arginine Methylation of the Tumor Suppressor Programmed Cell Death 4
Matthew A. Powers et al.
CANCER RESEARCH (2011)
Evolution of Gene Regulatory Networks Controlling Body Plan Development
Isabelle S. Peter et al.
CELL (2011)
Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation
Jung-Mao Hsu et al.
NATURE CELL BIOLOGY (2011)
Yes-Associated Protein Expression in Head and Neck Squamous Cell Carcinoma Nodal Metastasis
Lin Ge et al.
PLOS ONE (2011)
Versatility of PRMT5-induced methylation in growth control and development
Vrajesh Karkhanis et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Arginine methylation regulates the p53 response
Martin Jansson et al.
NATURE CELL BIOLOGY (2008)
Current opinion in diagnosis and treatment of laryngeal carcinoma
Gino Marioni et al.
CANCER TREATMENT REVIEWS (2006)
Multifunctional transcription factor YY1: a therapeutic target in human cancer?
CC Wang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
Transcription factor YY1: structure, function, and therapeutic implications in cancer biology
S Gordon et al.
ONCOGENE (2006)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)